nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—ABCB1—kidney cancer	0.0886	1	CbGaD
Aripiprazole—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0415	0.0777	CbGbCtD
Aripiprazole—CYP3A7—Temsirolimus—kidney cancer	0.0415	0.0777	CbGbCtD
Aripiprazole—CYP3A5—Temsirolimus—kidney cancer	0.0311	0.0583	CbGbCtD
Aripiprazole—HTR2B—Sorafenib—kidney cancer	0.0298	0.0559	CbGbCtD
Aripiprazole—ABCB1—Temsirolimus—kidney cancer	0.0203	0.038	CbGbCtD
Aripiprazole—KCNH2—Sunitinib—kidney cancer	0.02	0.0375	CbGbCtD
Aripiprazole—HTR2C—Sorafenib—kidney cancer	0.0194	0.0364	CbGbCtD
Aripiprazole—CYP2D6—Temsirolimus—kidney cancer	0.0191	0.0358	CbGbCtD
Aripiprazole—CYP3A4—Everolimus—kidney cancer	0.018	0.0337	CbGbCtD
Aripiprazole—CYP3A7—Paclitaxel—kidney cancer	0.0142	0.0267	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0142	0.0267	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0126	0.0237	CbGbCtD
Aripiprazole—CYP3A7—Sorafenib—kidney cancer	0.0126	0.0237	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0123	0.023	CbGbCtD
Aripiprazole—CYP3A7—Vincristine—kidney cancer	0.0123	0.023	CbGbCtD
Aripiprazole—CYP3A4—Temsirolimus—kidney cancer	0.0121	0.0227	CbGbCtD
Aripiprazole—CYP3A5—Erlotinib—kidney cancer	0.0117	0.0219	CbGbCtD
Aripiprazole—CYP3A5—Paclitaxel—kidney cancer	0.0107	0.02	CbGbCtD
Aripiprazole—ABCB1—Pazopanib—kidney cancer	0.0106	0.0199	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0102	0.0192	CbGbCtD
Aripiprazole—CYP3A7—Sunitinib—kidney cancer	0.0102	0.0192	CbGbCtD
Aripiprazole—CYP2D6—Pazopanib—kidney cancer	0.01	0.0188	CbGbCtD
Aripiprazole—ABCB1—Dactinomycin—kidney cancer	0.00973	0.0182	CbGbCtD
Aripiprazole—CYP3A5—Sorafenib—kidney cancer	0.00948	0.0178	CbGbCtD
Aripiprazole—CYP3A5—Vincristine—kidney cancer	0.00921	0.0173	CbGbCtD
Aripiprazole—ABCB1—Gemcitabine—kidney cancer	0.00769	0.0144	CbGbCtD
Aripiprazole—CYP3A5—Sunitinib—kidney cancer	0.00768	0.0144	CbGbCtD
Aripiprazole—ABCB1—Erlotinib—kidney cancer	0.00759	0.0142	CbGbCtD
Aripiprazole—CYP2D6—Erlotinib—kidney cancer	0.00715	0.0134	CbGbCtD
Aripiprazole—ABCB1—Paclitaxel—kidney cancer	0.00695	0.013	CbGbCtD
Aripiprazole—CHRM3—ureter—kidney cancer	0.00638	0.204	CbGeAlD
Aripiprazole—CYP3A4—Pazopanib—kidney cancer	0.00637	0.0119	CbGbCtD
Aripiprazole—ABCB1—Sorafenib—kidney cancer	0.00617	0.0116	CbGbCtD
Aripiprazole—ABCB1—Vinblastine—kidney cancer	0.0061	0.0114	CbGbCtD
Aripiprazole—ABCB1—Vincristine—kidney cancer	0.00599	0.0112	CbGbCtD
Aripiprazole—CYP2D6—Sorafenib—kidney cancer	0.00582	0.0109	CbGbCtD
Aripiprazole—CYP2D6—Vinblastine—kidney cancer	0.00574	0.0108	CbGbCtD
Aripiprazole—ABCB1—Sunitinib—kidney cancer	0.005	0.00937	CbGbCtD
Aripiprazole—CYP3A4—Erlotinib—kidney cancer	0.00455	0.00852	CbGbCtD
Aripiprazole—CYP3A4—Paclitaxel—kidney cancer	0.00416	0.0078	CbGbCtD
Aripiprazole—ABCB1—Doxorubicin—kidney cancer	0.00375	0.00702	CbGbCtD
Aripiprazole—CYP3A4—Sorafenib—kidney cancer	0.0037	0.00693	CbGbCtD
Aripiprazole—CYP3A4—Vinblastine—kidney cancer	0.00365	0.00684	CbGbCtD
Aripiprazole—CYP3A4—Vincristine—kidney cancer	0.00359	0.00673	CbGbCtD
Aripiprazole—CYP2D6—Doxorubicin—kidney cancer	0.00353	0.00661	CbGbCtD
Aripiprazole—CYP3A4—Sunitinib—kidney cancer	0.003	0.00562	CbGbCtD
Aripiprazole—CYP3A4—Doxorubicin—kidney cancer	0.00224	0.00421	CbGbCtD
Aripiprazole—HTR2A—urine—kidney cancer	0.00123	0.0393	CbGeAlD
Aripiprazole—CYP3A4—urine—kidney cancer	0.00114	0.0364	CbGeAlD
Aripiprazole—CYP2D6—urine—kidney cancer	0.00112	0.0358	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000987	0.0316	CbGeAlD
Aripiprazole—H1F0—nephron tubule—kidney cancer	0.000861	0.0275	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000845	0.027	CbGeAlD
Aripiprazole—ADRA1B—renal system—kidney cancer	0.000829	0.0265	CbGeAlD
Aripiprazole—ADRA1B—kidney—kidney cancer	0.000801	0.0256	CbGeAlD
Aripiprazole—H1F0—renal system—kidney cancer	0.000782	0.025	CbGeAlD
Aripiprazole—H1F0—kidney—kidney cancer	0.000756	0.0242	CbGeAlD
Aripiprazole—H1F0—cortex of kidney—kidney cancer	0.000737	0.0236	CbGeAlD
Aripiprazole—H1F0—gonad—kidney cancer	0.000702	0.0224	CbGeAlD
Aripiprazole—H1F0—cardiac atrium—kidney cancer	0.000701	0.0224	CbGeAlD
Aripiprazole—HTR1D—kidney—kidney cancer	0.000586	0.0187	CbGeAlD
Aripiprazole—HTR2B—cortex of kidney—kidney cancer	0.000531	0.017	CbGeAlD
Aripiprazole—ADRB1—cardiac atrium—kidney cancer	0.000527	0.0169	CbGeAlD
Aripiprazole—CHRM3—renal system—kidney cancer	0.000507	0.0162	CbGeAlD
Aripiprazole—HTR1A—renal system—kidney cancer	0.000505	0.0162	CbGeAlD
Aripiprazole—CHRM3—kidney—kidney cancer	0.00049	0.0157	CbGeAlD
Aripiprazole—ADRA2C—nephron tubule—kidney cancer	0.000488	0.0156	CbGeAlD
Aripiprazole—HTR7—renal system—kidney cancer	0.000483	0.0154	CbGeAlD
Aripiprazole—HTR7—kidney—kidney cancer	0.000467	0.0149	CbGeAlD
Aripiprazole—ADRA1A—renal system—kidney cancer	0.000466	0.0149	CbGeAlD
Aripiprazole—KCNH2—renal system—kidney cancer	0.00045	0.0144	CbGeAlD
Aripiprazole—ADRA2C—renal system—kidney cancer	0.000444	0.0142	CbGeAlD
Aripiprazole—HTR7—gonad—kidney cancer	0.000433	0.0138	CbGeAlD
Aripiprazole—ADRA2C—kidney—kidney cancer	0.000429	0.0137	CbGeAlD
Aripiprazole—ADRA2C—cortex of kidney—kidney cancer	0.000418	0.0134	CbGeAlD
Aripiprazole—CYP3A5—nephron tubule—kidney cancer	0.000409	0.0131	CbGeAlD
Aripiprazole—KCNH2—cardiac atrium—kidney cancer	0.000403	0.0129	CbGeAlD
Aripiprazole—ADRA2C—cardiac atrium—kidney cancer	0.000397	0.0127	CbGeAlD
Aripiprazole—CYP3A5—renal system—kidney cancer	0.000371	0.0119	CbGeAlD
Aripiprazole—CYP3A5—kidney—kidney cancer	0.000359	0.0115	CbGeAlD
Aripiprazole—CYP3A5—cortex of kidney—kidney cancer	0.00035	0.0112	CbGeAlD
Aripiprazole—ADRA2A—cortex of kidney—kidney cancer	0.000333	0.0107	CbGeAlD
Aripiprazole—ADRA2A—gonad—kidney cancer	0.000317	0.0102	CbGeAlD
Aripiprazole—ADRA2A—cardiac atrium—kidney cancer	0.000317	0.0101	CbGeAlD
Aripiprazole—HTR2A—renal system—kidney cancer	0.000301	0.00963	CbGeAlD
Aripiprazole—HTR2A—kidney—kidney cancer	0.000291	0.00931	CbGeAlD
Aripiprazole—CYP3A4—renal system—kidney cancer	0.000279	0.00891	CbGeAlD
Aripiprazole—CYP2D6—renal system—kidney cancer	0.000274	0.00877	CbGeAlD
Aripiprazole—HTR2A—gonad—kidney cancer	0.00027	0.00863	CbGeAlD
Aripiprazole—CYP3A4—kidney—kidney cancer	0.000269	0.00862	CbGeAlD
Aripiprazole—CYP2D6—kidney—kidney cancer	0.000265	0.00848	CbGeAlD
Aripiprazole—ABCB1—nephron tubule—kidney cancer	0.000217	0.00694	CbGeAlD
Aripiprazole—ABCB1—renal system—kidney cancer	0.000197	0.00631	CbGeAlD
Aripiprazole—ABCB1—kidney—kidney cancer	0.000191	0.0061	CbGeAlD
Aripiprazole—ABCB1—cortex of kidney—kidney cancer	0.000186	0.00594	CbGeAlD
Aripiprazole—ABCB1—gonad—kidney cancer	0.000177	0.00566	CbGeAlD
Aripiprazole—Shock—Paclitaxel—kidney cancer	3.73e-05	0.00013	CcSEcCtD
Aripiprazole—Vomiting—Sorafenib—kidney cancer	3.73e-05	0.00013	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Doxorubicin—kidney cancer	3.73e-05	0.000129	CcSEcCtD
Aripiprazole—Abdominal pain upper—Doxorubicin—kidney cancer	3.73e-05	0.000129	CcSEcCtD
Aripiprazole—Nervous system disorder—Paclitaxel—kidney cancer	3.72e-05	0.000129	CcSEcCtD
Aripiprazole—Hypokalaemia—Doxorubicin—kidney cancer	3.71e-05	0.000129	CcSEcCtD
Aripiprazole—Thrombocytopenia—Paclitaxel—kidney cancer	3.71e-05	0.000129	CcSEcCtD
Aripiprazole—Tachycardia—Paclitaxel—kidney cancer	3.7e-05	0.000129	CcSEcCtD
Aripiprazole—Rash—Sorafenib—kidney cancer	3.7e-05	0.000128	CcSEcCtD
Aripiprazole—Dermatitis—Sorafenib—kidney cancer	3.69e-05	0.000128	CcSEcCtD
Aripiprazole—Back pain—Capecitabine—kidney cancer	3.69e-05	0.000128	CcSEcCtD
Aripiprazole—Breast disorder—Doxorubicin—kidney cancer	3.69e-05	0.000128	CcSEcCtD
Aripiprazole—Skin disorder—Paclitaxel—kidney cancer	3.68e-05	0.000128	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	3.67e-05	0.000128	CcSEcCtD
Aripiprazole—Headache—Sorafenib—kidney cancer	3.67e-05	0.000128	CcSEcCtD
Aripiprazole—Muscle spasms—Capecitabine—kidney cancer	3.66e-05	0.000127	CcSEcCtD
Aripiprazole—Hyperhidrosis—Paclitaxel—kidney cancer	3.66e-05	0.000127	CcSEcCtD
Aripiprazole—Diarrhoea—Dactinomycin—kidney cancer	3.65e-05	0.000127	CcSEcCtD
Aripiprazole—Nasopharyngitis—Doxorubicin—kidney cancer	3.65e-05	0.000127	CcSEcCtD
Aripiprazole—Anorexia—Paclitaxel—kidney cancer	3.61e-05	0.000126	CcSEcCtD
Aripiprazole—Gastritis—Doxorubicin—kidney cancer	3.61e-05	0.000125	CcSEcCtD
Aripiprazole—Muscular weakness—Doxorubicin—kidney cancer	3.6e-05	0.000125	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	3.6e-05	0.000125	CcSEcCtD
Aripiprazole—Vision blurred—Capecitabine—kidney cancer	3.59e-05	0.000125	CcSEcCtD
Aripiprazole—Vomiting—Sunitinib—kidney cancer	3.59e-05	0.000125	CcSEcCtD
Aripiprazole—Body temperature increased—Gemcitabine—kidney cancer	3.58e-05	0.000124	CcSEcCtD
Aripiprazole—Tremor—Capecitabine—kidney cancer	3.57e-05	0.000124	CcSEcCtD
Aripiprazole—Rash—Sunitinib—kidney cancer	3.56e-05	0.000124	CcSEcCtD
Aripiprazole—Dermatitis—Sunitinib—kidney cancer	3.55e-05	0.000124	CcSEcCtD
Aripiprazole—Abdominal distension—Doxorubicin—kidney cancer	3.55e-05	0.000123	CcSEcCtD
Aripiprazole—Hypotension—Paclitaxel—kidney cancer	3.54e-05	0.000123	CcSEcCtD
Aripiprazole—Ill-defined disorder—Capecitabine—kidney cancer	3.54e-05	0.000123	CcSEcCtD
Aripiprazole—Headache—Sunitinib—kidney cancer	3.53e-05	0.000123	CcSEcCtD
Aripiprazole—Asthma—Doxorubicin—kidney cancer	3.53e-05	0.000123	CcSEcCtD
Aripiprazole—Dysphagia—Doxorubicin—kidney cancer	3.53e-05	0.000123	CcSEcCtD
Aripiprazole—Influenza—Doxorubicin—kidney cancer	3.53e-05	0.000123	CcSEcCtD
Aripiprazole—Anaemia—Capecitabine—kidney cancer	3.52e-05	0.000122	CcSEcCtD
Aripiprazole—Hypersensitivity—Vincristine—kidney cancer	3.52e-05	0.000122	CcSEcCtD
Aripiprazole—Eosinophilia—Doxorubicin—kidney cancer	3.49e-05	0.000121	CcSEcCtD
Aripiprazole—Nausea—Sorafenib—kidney cancer	3.48e-05	0.000121	CcSEcCtD
Aripiprazole—Pancreatitis—Doxorubicin—kidney cancer	3.46e-05	0.00012	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.45e-05	0.00012	CcSEcCtD
Aripiprazole—Malaise—Capecitabine—kidney cancer	3.44e-05	0.000119	CcSEcCtD
Aripiprazole—Angina pectoris—Doxorubicin—kidney cancer	3.43e-05	0.000119	CcSEcCtD
Aripiprazole—Insomnia—Paclitaxel—kidney cancer	3.43e-05	0.000119	CcSEcCtD
Aripiprazole—Vertigo—Capecitabine—kidney cancer	3.42e-05	0.000119	CcSEcCtD
Aripiprazole—Asthenia—Vincristine—kidney cancer	3.42e-05	0.000119	CcSEcCtD
Aripiprazole—Syncope—Capecitabine—kidney cancer	3.42e-05	0.000119	CcSEcCtD
Aripiprazole—Leukopenia—Capecitabine—kidney cancer	3.41e-05	0.000119	CcSEcCtD
Aripiprazole—Paraesthesia—Paclitaxel—kidney cancer	3.4e-05	0.000118	CcSEcCtD
Aripiprazole—Vomiting—Dactinomycin—kidney cancer	3.4e-05	0.000118	CcSEcCtD
Aripiprazole—Dyspnoea—Paclitaxel—kidney cancer	3.38e-05	0.000117	CcSEcCtD
Aripiprazole—Somnolence—Paclitaxel—kidney cancer	3.37e-05	0.000117	CcSEcCtD
Aripiprazole—Palpitations—Capecitabine—kidney cancer	3.37e-05	0.000117	CcSEcCtD
Aripiprazole—Rash—Dactinomycin—kidney cancer	3.37e-05	0.000117	CcSEcCtD
Aripiprazole—Nausea—Sunitinib—kidney cancer	3.35e-05	0.000116	CcSEcCtD
Aripiprazole—Loss of consciousness—Capecitabine—kidney cancer	3.35e-05	0.000116	CcSEcCtD
Aripiprazole—Dyspepsia—Paclitaxel—kidney cancer	3.34e-05	0.000116	CcSEcCtD
Aripiprazole—Cough—Capecitabine—kidney cancer	3.33e-05	0.000116	CcSEcCtD
Aripiprazole—Neutropenia—Doxorubicin—kidney cancer	3.3e-05	0.000115	CcSEcCtD
Aripiprazole—Dysuria—Doxorubicin—kidney cancer	3.3e-05	0.000115	CcSEcCtD
Aripiprazole—Decreased appetite—Paclitaxel—kidney cancer	3.29e-05	0.000115	CcSEcCtD
Aripiprazole—Hypertension—Capecitabine—kidney cancer	3.29e-05	0.000114	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.28e-05	0.000114	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.27e-05	0.000114	CcSEcCtD
Aripiprazole—Fatigue—Paclitaxel—kidney cancer	3.27e-05	0.000114	CcSEcCtD
Aripiprazole—Diarrhoea—Vincristine—kidney cancer	3.26e-05	0.000113	CcSEcCtD
Aripiprazole—Pollakiuria—Doxorubicin—kidney cancer	3.26e-05	0.000113	CcSEcCtD
Aripiprazole—Asthenia—Gemcitabine—kidney cancer	3.25e-05	0.000113	CcSEcCtD
Aripiprazole—Chest pain—Capecitabine—kidney cancer	3.24e-05	0.000113	CcSEcCtD
Aripiprazole—Arthralgia—Capecitabine—kidney cancer	3.24e-05	0.000113	CcSEcCtD
Aripiprazole—Myalgia—Capecitabine—kidney cancer	3.24e-05	0.000113	CcSEcCtD
Aripiprazole—Pain—Paclitaxel—kidney cancer	3.24e-05	0.000113	CcSEcCtD
Aripiprazole—Constipation—Paclitaxel—kidney cancer	3.24e-05	0.000113	CcSEcCtD
Aripiprazole—Anxiety—Capecitabine—kidney cancer	3.23e-05	0.000112	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.22e-05	0.000112	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Doxorubicin—kidney cancer	3.22e-05	0.000112	CcSEcCtD
Aripiprazole—Weight increased—Doxorubicin—kidney cancer	3.21e-05	0.000112	CcSEcCtD
Aripiprazole—Discomfort—Capecitabine—kidney cancer	3.21e-05	0.000111	CcSEcCtD
Aripiprazole—Pruritus—Gemcitabine—kidney cancer	3.2e-05	0.000111	CcSEcCtD
Aripiprazole—Weight decreased—Doxorubicin—kidney cancer	3.19e-05	0.000111	CcSEcCtD
Aripiprazole—Hyperglycaemia—Doxorubicin—kidney cancer	3.18e-05	0.000111	CcSEcCtD
Aripiprazole—Dry mouth—Capecitabine—kidney cancer	3.17e-05	0.00011	CcSEcCtD
Aripiprazole—Nausea—Dactinomycin—kidney cancer	3.17e-05	0.00011	CcSEcCtD
Aripiprazole—Pneumonia—Doxorubicin—kidney cancer	3.16e-05	0.00011	CcSEcCtD
Aripiprazole—Dizziness—Vincristine—kidney cancer	3.16e-05	0.00011	CcSEcCtD
Aripiprazole—Infestation NOS—Doxorubicin—kidney cancer	3.14e-05	0.000109	CcSEcCtD
Aripiprazole—Infestation—Doxorubicin—kidney cancer	3.14e-05	0.000109	CcSEcCtD
Aripiprazole—Confusional state—Capecitabine—kidney cancer	3.14e-05	0.000109	CcSEcCtD
Aripiprazole—Feeling abnormal—Paclitaxel—kidney cancer	3.12e-05	0.000109	CcSEcCtD
Aripiprazole—Oedema—Capecitabine—kidney cancer	3.11e-05	0.000108	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Paclitaxel—kidney cancer	3.1e-05	0.000108	CcSEcCtD
Aripiprazole—Diarrhoea—Gemcitabine—kidney cancer	3.1e-05	0.000108	CcSEcCtD
Aripiprazole—Renal failure—Doxorubicin—kidney cancer	3.09e-05	0.000107	CcSEcCtD
Aripiprazole—Infection—Capecitabine—kidney cancer	3.09e-05	0.000107	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Doxorubicin—kidney cancer	3.08e-05	0.000107	CcSEcCtD
Aripiprazole—Stomatitis—Doxorubicin—kidney cancer	3.06e-05	0.000106	CcSEcCtD
Aripiprazole—Jaundice—Doxorubicin—kidney cancer	3.06e-05	0.000106	CcSEcCtD
Aripiprazole—Shock—Capecitabine—kidney cancer	3.06e-05	0.000106	CcSEcCtD
Aripiprazole—Conjunctivitis—Doxorubicin—kidney cancer	3.06e-05	0.000106	CcSEcCtD
Aripiprazole—Urinary tract infection—Doxorubicin—kidney cancer	3.06e-05	0.000106	CcSEcCtD
Aripiprazole—Nervous system disorder—Capecitabine—kidney cancer	3.05e-05	0.000106	CcSEcCtD
Aripiprazole—Thrombocytopenia—Capecitabine—kidney cancer	3.05e-05	0.000106	CcSEcCtD
Aripiprazole—Tachycardia—Capecitabine—kidney cancer	3.04e-05	0.000105	CcSEcCtD
Aripiprazole—Vomiting—Vincristine—kidney cancer	3.03e-05	0.000105	CcSEcCtD
Aripiprazole—Skin disorder—Capecitabine—kidney cancer	3.02e-05	0.000105	CcSEcCtD
Aripiprazole—Sweating—Doxorubicin—kidney cancer	3.01e-05	0.000105	CcSEcCtD
Aripiprazole—Urticaria—Paclitaxel—kidney cancer	3.01e-05	0.000105	CcSEcCtD
Aripiprazole—Rash—Vincristine—kidney cancer	3.01e-05	0.000105	CcSEcCtD
Aripiprazole—Hyperhidrosis—Capecitabine—kidney cancer	3.01e-05	0.000104	CcSEcCtD
Aripiprazole—Dermatitis—Vincristine—kidney cancer	3.01e-05	0.000104	CcSEcCtD
Aripiprazole—Haematuria—Doxorubicin—kidney cancer	3e-05	0.000104	CcSEcCtD
Aripiprazole—Abdominal pain—Paclitaxel—kidney cancer	3e-05	0.000104	CcSEcCtD
Aripiprazole—Body temperature increased—Paclitaxel—kidney cancer	3e-05	0.000104	CcSEcCtD
Aripiprazole—Headache—Vincristine—kidney cancer	2.99e-05	0.000104	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Doxorubicin—kidney cancer	2.97e-05	0.000103	CcSEcCtD
Aripiprazole—Epistaxis—Doxorubicin—kidney cancer	2.96e-05	0.000103	CcSEcCtD
Aripiprazole—Anorexia—Capecitabine—kidney cancer	2.96e-05	0.000103	CcSEcCtD
Aripiprazole—Sinusitis—Doxorubicin—kidney cancer	2.95e-05	0.000102	CcSEcCtD
Aripiprazole—Agranulocytosis—Doxorubicin—kidney cancer	2.93e-05	0.000102	CcSEcCtD
Aripiprazole—Hypotension—Capecitabine—kidney cancer	2.91e-05	0.000101	CcSEcCtD
Aripiprazole—Vomiting—Gemcitabine—kidney cancer	2.88e-05	0.0001	CcSEcCtD
Aripiprazole—Bradycardia—Doxorubicin—kidney cancer	2.87e-05	9.98e-05	CcSEcCtD
Aripiprazole—Rash—Gemcitabine—kidney cancer	2.85e-05	9.92e-05	CcSEcCtD
Aripiprazole—Dermatitis—Gemcitabine—kidney cancer	2.85e-05	9.91e-05	CcSEcCtD
Aripiprazole—Haemoglobin—Doxorubicin—kidney cancer	2.84e-05	9.86e-05	CcSEcCtD
Aripiprazole—Headache—Gemcitabine—kidney cancer	2.84e-05	9.86e-05	CcSEcCtD
Aripiprazole—Nausea—Vincristine—kidney cancer	2.83e-05	9.85e-05	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.83e-05	9.85e-05	CcSEcCtD
Aripiprazole—Rhinitis—Doxorubicin—kidney cancer	2.83e-05	9.83e-05	CcSEcCtD
Aripiprazole—Haemorrhage—Doxorubicin—kidney cancer	2.82e-05	9.81e-05	CcSEcCtD
Aripiprazole—Hepatitis—Doxorubicin—kidney cancer	2.82e-05	9.81e-05	CcSEcCtD
Aripiprazole—Insomnia—Capecitabine—kidney cancer	2.81e-05	9.78e-05	CcSEcCtD
Aripiprazole—Hypoaesthesia—Doxorubicin—kidney cancer	2.81e-05	9.76e-05	CcSEcCtD
Aripiprazole—Pharyngitis—Doxorubicin—kidney cancer	2.8e-05	9.73e-05	CcSEcCtD
Aripiprazole—Paraesthesia—Capecitabine—kidney cancer	2.79e-05	9.71e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Paclitaxel—kidney cancer	2.79e-05	9.7e-05	CcSEcCtD
Aripiprazole—Urinary tract disorder—Doxorubicin—kidney cancer	2.79e-05	9.69e-05	CcSEcCtD
Aripiprazole—Oedema peripheral—Doxorubicin—kidney cancer	2.78e-05	9.66e-05	CcSEcCtD
Aripiprazole—Connective tissue disorder—Doxorubicin—kidney cancer	2.77e-05	9.64e-05	CcSEcCtD
Aripiprazole—Dyspnoea—Capecitabine—kidney cancer	2.77e-05	9.64e-05	CcSEcCtD
Aripiprazole—Urethral disorder—Doxorubicin—kidney cancer	2.77e-05	9.61e-05	CcSEcCtD
Aripiprazole—Dyspepsia—Capecitabine—kidney cancer	2.74e-05	9.51e-05	CcSEcCtD
Aripiprazole—Visual impairment—Doxorubicin—kidney cancer	2.72e-05	9.45e-05	CcSEcCtD
Aripiprazole—Asthenia—Paclitaxel—kidney cancer	2.72e-05	9.45e-05	CcSEcCtD
Aripiprazole—Decreased appetite—Capecitabine—kidney cancer	2.7e-05	9.4e-05	CcSEcCtD
Aripiprazole—Nausea—Gemcitabine—kidney cancer	2.69e-05	9.34e-05	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Capecitabine—kidney cancer	2.69e-05	9.33e-05	CcSEcCtD
Aripiprazole—Fatigue—Capecitabine—kidney cancer	2.68e-05	9.32e-05	CcSEcCtD
Aripiprazole—Pruritus—Paclitaxel—kidney cancer	2.68e-05	9.32e-05	CcSEcCtD
Aripiprazole—Pain—Capecitabine—kidney cancer	2.66e-05	9.24e-05	CcSEcCtD
Aripiprazole—Constipation—Capecitabine—kidney cancer	2.66e-05	9.24e-05	CcSEcCtD
Aripiprazole—Eye disorder—Doxorubicin—kidney cancer	2.64e-05	9.17e-05	CcSEcCtD
Aripiprazole—Tinnitus—Doxorubicin—kidney cancer	2.63e-05	9.14e-05	CcSEcCtD
Aripiprazole—Cardiac disorder—Doxorubicin—kidney cancer	2.62e-05	9.1e-05	CcSEcCtD
Aripiprazole—Flushing—Doxorubicin—kidney cancer	2.62e-05	9.1e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Paclitaxel—kidney cancer	2.59e-05	9.01e-05	CcSEcCtD
Aripiprazole—Feeling abnormal—Capecitabine—kidney cancer	2.56e-05	8.91e-05	CcSEcCtD
Aripiprazole—Angiopathy—Doxorubicin—kidney cancer	2.56e-05	8.9e-05	CcSEcCtD
Aripiprazole—Immune system disorder—Doxorubicin—kidney cancer	2.55e-05	8.86e-05	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Capecitabine—kidney cancer	2.54e-05	8.84e-05	CcSEcCtD
Aripiprazole—Mediastinal disorder—Doxorubicin—kidney cancer	2.54e-05	8.84e-05	CcSEcCtD
Aripiprazole—Chills—Doxorubicin—kidney cancer	2.53e-05	8.8e-05	CcSEcCtD
Aripiprazole—Dizziness—Paclitaxel—kidney cancer	2.51e-05	8.71e-05	CcSEcCtD
Aripiprazole—Alopecia—Doxorubicin—kidney cancer	2.49e-05	8.67e-05	CcSEcCtD
Aripiprazole—Mental disorder—Doxorubicin—kidney cancer	2.47e-05	8.59e-05	CcSEcCtD
Aripiprazole—Urticaria—Capecitabine—kidney cancer	2.47e-05	8.59e-05	CcSEcCtD
Aripiprazole—Abdominal pain—Capecitabine—kidney cancer	2.46e-05	8.54e-05	CcSEcCtD
Aripiprazole—Body temperature increased—Capecitabine—kidney cancer	2.46e-05	8.54e-05	CcSEcCtD
Aripiprazole—Erythema—Doxorubicin—kidney cancer	2.46e-05	8.54e-05	CcSEcCtD
Aripiprazole—Malnutrition—Doxorubicin—kidney cancer	2.46e-05	8.54e-05	CcSEcCtD
Aripiprazole—Flatulence—Doxorubicin—kidney cancer	2.42e-05	8.41e-05	CcSEcCtD
Aripiprazole—Tension—Doxorubicin—kidney cancer	2.41e-05	8.38e-05	CcSEcCtD
Aripiprazole—Vomiting—Paclitaxel—kidney cancer	2.41e-05	8.37e-05	CcSEcCtD
Aripiprazole—Dysgeusia—Doxorubicin—kidney cancer	2.41e-05	8.36e-05	CcSEcCtD
Aripiprazole—Rash—Paclitaxel—kidney cancer	2.39e-05	8.3e-05	CcSEcCtD
Aripiprazole—Dermatitis—Paclitaxel—kidney cancer	2.39e-05	8.3e-05	CcSEcCtD
Aripiprazole—Nervousness—Doxorubicin—kidney cancer	2.39e-05	8.29e-05	CcSEcCtD
Aripiprazole—Back pain—Doxorubicin—kidney cancer	2.38e-05	8.26e-05	CcSEcCtD
Aripiprazole—Headache—Paclitaxel—kidney cancer	2.37e-05	8.25e-05	CcSEcCtD
Aripiprazole—Muscle spasms—Doxorubicin—kidney cancer	2.36e-05	8.21e-05	CcSEcCtD
Aripiprazole—Vision blurred—Doxorubicin—kidney cancer	2.31e-05	8.05e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Capecitabine—kidney cancer	2.29e-05	7.96e-05	CcSEcCtD
Aripiprazole—Ill-defined disorder—Doxorubicin—kidney cancer	2.28e-05	7.92e-05	CcSEcCtD
Aripiprazole—Anaemia—Doxorubicin—kidney cancer	2.27e-05	7.89e-05	CcSEcCtD
Aripiprazole—Agitation—Doxorubicin—kidney cancer	2.26e-05	7.85e-05	CcSEcCtD
Aripiprazole—Nausea—Paclitaxel—kidney cancer	2.25e-05	7.82e-05	CcSEcCtD
Aripiprazole—Asthenia—Capecitabine—kidney cancer	2.23e-05	7.76e-05	CcSEcCtD
Aripiprazole—Malaise—Doxorubicin—kidney cancer	2.22e-05	7.7e-05	CcSEcCtD
Aripiprazole—Vertigo—Doxorubicin—kidney cancer	2.21e-05	7.67e-05	CcSEcCtD
Aripiprazole—Syncope—Doxorubicin—kidney cancer	2.2e-05	7.66e-05	CcSEcCtD
Aripiprazole—Pruritus—Capecitabine—kidney cancer	2.2e-05	7.65e-05	CcSEcCtD
Aripiprazole—Leukopenia—Doxorubicin—kidney cancer	2.2e-05	7.64e-05	CcSEcCtD
Aripiprazole—Palpitations—Doxorubicin—kidney cancer	2.17e-05	7.54e-05	CcSEcCtD
Aripiprazole—Loss of consciousness—Doxorubicin—kidney cancer	2.16e-05	7.5e-05	CcSEcCtD
Aripiprazole—Cough—Doxorubicin—kidney cancer	2.14e-05	7.45e-05	CcSEcCtD
Aripiprazole—Convulsion—Doxorubicin—kidney cancer	2.13e-05	7.4e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Capecitabine—kidney cancer	2.13e-05	7.4e-05	CcSEcCtD
Aripiprazole—Hypertension—Doxorubicin—kidney cancer	2.12e-05	7.37e-05	CcSEcCtD
Aripiprazole—Arthralgia—Doxorubicin—kidney cancer	2.09e-05	7.27e-05	CcSEcCtD
Aripiprazole—Chest pain—Doxorubicin—kidney cancer	2.09e-05	7.27e-05	CcSEcCtD
Aripiprazole—Myalgia—Doxorubicin—kidney cancer	2.09e-05	7.27e-05	CcSEcCtD
Aripiprazole—Anxiety—Doxorubicin—kidney cancer	2.08e-05	7.24e-05	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.08e-05	7.22e-05	CcSEcCtD
Aripiprazole—Discomfort—Doxorubicin—kidney cancer	2.07e-05	7.18e-05	CcSEcCtD
Aripiprazole—Dizziness—Capecitabine—kidney cancer	2.06e-05	7.15e-05	CcSEcCtD
Aripiprazole—Dry mouth—Doxorubicin—kidney cancer	2.05e-05	7.11e-05	CcSEcCtD
Aripiprazole—Confusional state—Doxorubicin—kidney cancer	2.02e-05	7.03e-05	CcSEcCtD
Aripiprazole—Oedema—Doxorubicin—kidney cancer	2e-05	6.97e-05	CcSEcCtD
Aripiprazole—Anaphylactic shock—Doxorubicin—kidney cancer	2e-05	6.97e-05	CcSEcCtD
Aripiprazole—Infection—Doxorubicin—kidney cancer	1.99e-05	6.92e-05	CcSEcCtD
Aripiprazole—Vomiting—Capecitabine—kidney cancer	1.98e-05	6.87e-05	CcSEcCtD
Aripiprazole—Shock—Doxorubicin—kidney cancer	1.97e-05	6.86e-05	CcSEcCtD
Aripiprazole—Nervous system disorder—Doxorubicin—kidney cancer	1.97e-05	6.83e-05	CcSEcCtD
Aripiprazole—Thrombocytopenia—Doxorubicin—kidney cancer	1.96e-05	6.82e-05	CcSEcCtD
Aripiprazole—Rash—Capecitabine—kidney cancer	1.96e-05	6.82e-05	CcSEcCtD
Aripiprazole—Dermatitis—Capecitabine—kidney cancer	1.96e-05	6.81e-05	CcSEcCtD
Aripiprazole—Tachycardia—Doxorubicin—kidney cancer	1.96e-05	6.8e-05	CcSEcCtD
Aripiprazole—Headache—Capecitabine—kidney cancer	1.95e-05	6.77e-05	CcSEcCtD
Aripiprazole—Skin disorder—Doxorubicin—kidney cancer	1.95e-05	6.77e-05	CcSEcCtD
Aripiprazole—Hyperhidrosis—Doxorubicin—kidney cancer	1.94e-05	6.74e-05	CcSEcCtD
Aripiprazole—Anorexia—Doxorubicin—kidney cancer	1.91e-05	6.64e-05	CcSEcCtD
Aripiprazole—Hypotension—Doxorubicin—kidney cancer	1.87e-05	6.51e-05	CcSEcCtD
Aripiprazole—Nausea—Capecitabine—kidney cancer	1.85e-05	6.42e-05	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.83e-05	6.35e-05	CcSEcCtD
Aripiprazole—Insomnia—Doxorubicin—kidney cancer	1.81e-05	6.3e-05	CcSEcCtD
Aripiprazole—Paraesthesia—Doxorubicin—kidney cancer	1.8e-05	6.26e-05	CcSEcCtD
Aripiprazole—Dyspnoea—Doxorubicin—kidney cancer	1.79e-05	6.21e-05	CcSEcCtD
Aripiprazole—Somnolence—Doxorubicin—kidney cancer	1.78e-05	6.19e-05	CcSEcCtD
Aripiprazole—Dyspepsia—Doxorubicin—kidney cancer	1.76e-05	6.13e-05	CcSEcCtD
Aripiprazole—Decreased appetite—Doxorubicin—kidney cancer	1.74e-05	6.06e-05	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.73e-05	6.02e-05	CcSEcCtD
Aripiprazole—Fatigue—Doxorubicin—kidney cancer	1.73e-05	6.01e-05	CcSEcCtD
Aripiprazole—Constipation—Doxorubicin—kidney cancer	1.71e-05	5.96e-05	CcSEcCtD
Aripiprazole—Pain—Doxorubicin—kidney cancer	1.71e-05	5.96e-05	CcSEcCtD
Aripiprazole—Feeling abnormal—Doxorubicin—kidney cancer	1.65e-05	5.74e-05	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Doxorubicin—kidney cancer	1.64e-05	5.7e-05	CcSEcCtD
Aripiprazole—Urticaria—Doxorubicin—kidney cancer	1.59e-05	5.54e-05	CcSEcCtD
Aripiprazole—Abdominal pain—Doxorubicin—kidney cancer	1.58e-05	5.51e-05	CcSEcCtD
Aripiprazole—Body temperature increased—Doxorubicin—kidney cancer	1.58e-05	5.51e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Doxorubicin—kidney cancer	1.48e-05	5.13e-05	CcSEcCtD
Aripiprazole—Asthenia—Doxorubicin—kidney cancer	1.44e-05	5e-05	CcSEcCtD
Aripiprazole—Pruritus—Doxorubicin—kidney cancer	1.42e-05	4.93e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Doxorubicin—kidney cancer	1.37e-05	4.77e-05	CcSEcCtD
Aripiprazole—Dizziness—Doxorubicin—kidney cancer	1.33e-05	4.61e-05	CcSEcCtD
Aripiprazole—Vomiting—Doxorubicin—kidney cancer	1.27e-05	4.43e-05	CcSEcCtD
Aripiprazole—Rash—Doxorubicin—kidney cancer	1.26e-05	4.39e-05	CcSEcCtD
Aripiprazole—Dermatitis—Doxorubicin—kidney cancer	1.26e-05	4.39e-05	CcSEcCtD
Aripiprazole—Headache—Doxorubicin—kidney cancer	1.26e-05	4.36e-05	CcSEcCtD
Aripiprazole—Nausea—Doxorubicin—kidney cancer	1.19e-05	4.14e-05	CcSEcCtD
Aripiprazole—HRH1—Signaling Pathways—RAF1—kidney cancer	2.7e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.7e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.69e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—RELA—kidney cancer	2.69e-06	4.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—RAF1—kidney cancer	2.69e-06	4.57e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—RELA—kidney cancer	2.68e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MTOR—kidney cancer	2.68e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—RAF1—kidney cancer	2.68e-06	4.55e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MYC—kidney cancer	2.68e-06	4.55e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—RELA—kidney cancer	2.67e-06	4.55e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.67e-06	4.54e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	2.67e-06	4.54e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—kidney cancer	2.67e-06	4.54e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.67e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—RELA—kidney cancer	2.67e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.66e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—KRAS—kidney cancer	2.66e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ERBB2—kidney cancer	2.66e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—RAF1—kidney cancer	2.65e-06	4.51e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ERBB2—kidney cancer	2.65e-06	4.5e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.65e-06	4.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CCND1—kidney cancer	2.64e-06	4.49e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MAPK1—kidney cancer	2.64e-06	4.49e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—RELA—kidney cancer	2.64e-06	4.49e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—JUN—kidney cancer	2.64e-06	4.49e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.64e-06	4.48e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.64e-06	4.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.63e-06	4.48e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MTOR—kidney cancer	2.63e-06	4.47e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.62e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ERBB2—kidney cancer	2.62e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MTOR—kidney cancer	2.62e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK3—kidney cancer	2.62e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	2.62e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MAPK1—kidney cancer	2.62e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2.62e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—KRAS—kidney cancer	2.62e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MTOR—kidney cancer	2.61e-06	4.44e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—kidney cancer	2.61e-06	4.43e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCND1—kidney cancer	2.6e-06	4.42e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—JUN—kidney cancer	2.6e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MTOR—kidney cancer	2.59e-06	4.4e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK3—kidney cancer	2.59e-06	4.4e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MTOR—kidney cancer	2.58e-06	4.39e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—KRAS—kidney cancer	2.58e-06	4.39e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	2.58e-06	4.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PTEN—kidney cancer	2.55e-06	4.34e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MYC—kidney cancer	2.55e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—kidney cancer	2.52e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.52e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—PIK3CA—kidney cancer	2.51e-06	4.27e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PTEN—kidney cancer	2.51e-06	4.27e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—PIK3CA—kidney cancer	2.51e-06	4.27e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—KRAS—kidney cancer	2.5e-06	4.25e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	2.49e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK1—kidney cancer	2.49e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—kidney cancer	2.49e-06	4.23e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTEN—kidney cancer	2.48e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.48e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.48e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—KRAS—kidney cancer	2.47e-06	4.2e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.47e-06	4.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	2.47e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—POMC—kidney cancer	2.46e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	2.46e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—kidney cancer	2.46e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK1—kidney cancer	2.46e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RAF1—kidney cancer	2.46e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	2.45e-06	4.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.45e-06	4.16e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	2.44e-06	4.15e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—kidney cancer	2.43e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.43e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.43e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—kidney cancer	2.43e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.42e-06	4.12e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—kidney cancer	2.42e-06	4.12e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—kidney cancer	2.42e-06	4.11e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—kidney cancer	2.41e-06	4.1e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—kidney cancer	2.41e-06	4.09e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—PIK3CA—kidney cancer	2.4e-06	4.09e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—kidney cancer	2.4e-06	4.08e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCND1—kidney cancer	2.4e-06	4.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.4e-06	4.08e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—JUN—kidney cancer	2.39e-06	4.07e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.38e-06	4.05e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—kidney cancer	2.38e-06	4.04e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.38e-06	4.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—kidney cancer	2.36e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.36e-06	4.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK3—kidney cancer	2.36e-06	4e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—JUN—kidney cancer	2.36e-06	4e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCND1—kidney cancer	2.36e-06	4e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—KRAS—kidney cancer	2.36e-06	4e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—JUN—kidney cancer	2.35e-06	4e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.35e-06	3.99e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—JUN—kidney cancer	2.34e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.34e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.34e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTP1—kidney cancer	2.34e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—JUN—kidney cancer	2.34e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	2.33e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.33e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.33e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—kidney cancer	2.33e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—KRAS—kidney cancer	2.32e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—POMC—kidney cancer	2.32e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.32e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.32e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PTEN—kidney cancer	2.32e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—JUN—kidney cancer	2.31e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.31e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.31e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	2.31e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.3e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	2.29e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—kidney cancer	2.29e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—kidney cancer	2.29e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.29e-06	3.89e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.28e-06	3.87e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PTEN—kidney cancer	2.27e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTEN—kidney cancer	2.27e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	2.27e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—kidney cancer	2.27e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.27e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PTEN—kidney cancer	2.27e-06	3.85e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.26e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.25e-06	3.83e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.25e-06	3.83e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.24e-06	3.81e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK1—kidney cancer	2.24e-06	3.81e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.24e-06	3.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.23e-06	3.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	2.22e-06	3.78e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—kidney cancer	2.22e-06	3.77e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.22e-06	3.77e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCB1—kidney cancer	2.21e-06	3.76e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.2e-06	3.75e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—kidney cancer	2.2e-06	3.73e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—kidney cancer	2.19e-06	3.73e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	2.18e-06	3.71e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—kidney cancer	2.18e-06	3.71e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—kidney cancer	2.16e-06	3.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—kidney cancer	2.15e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—kidney cancer	2.15e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.15e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.15e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.14e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.14e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—kidney cancer	2.14e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.13e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.13e-06	3.62e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—kidney cancer	2.12e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—KRAS—kidney cancer	2.12e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—KRAS—kidney cancer	2.1e-06	3.57e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—kidney cancer	2.09e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.09e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.09e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	2.08e-06	3.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.07e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—kidney cancer	2.07e-06	3.51e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.06e-06	3.5e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.05e-06	3.49e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—kidney cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.04e-06	3.47e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—kidney cancer	2.04e-06	3.47e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.04e-06	3.46e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.03e-06	3.44e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2.02e-06	3.43e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	2.02e-06	3.43e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK3—kidney cancer	1.98e-06	3.36e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—kidney cancer	1.97e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—KRAS—kidney cancer	1.96e-06	3.33e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.95e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	1.95e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.94e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK3—kidney cancer	1.94e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.93e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—KRAS—kidney cancer	1.93e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	1.93e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—kidney cancer	1.92e-06	3.27e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.91e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.91e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—kidney cancer	1.91e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—kidney cancer	1.89e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—kidney cancer	1.89e-06	3.21e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—kidney cancer	1.88e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK1—kidney cancer	1.88e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—kidney cancer	1.88e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—kidney cancer	1.88e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.87e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—kidney cancer	1.86e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	1.86e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—kidney cancer	1.86e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.85e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.85e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—kidney cancer	1.85e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.85e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.85e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.84e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.84e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.82e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.81e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	1.8e-06	3.06e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—kidney cancer	1.8e-06	3.06e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—kidney cancer	1.79e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—KRAS—kidney cancer	1.78e-06	3.02e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.77e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.77e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.75e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.75e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—KRAS—kidney cancer	1.75e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—kidney cancer	1.74e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.74e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.72e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.72e-06	2.92e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTEN—kidney cancer	1.71e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.71e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.71e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.69e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.63e-06	2.78e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTEN—kidney cancer	1.62e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.61e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.6e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.6e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.6e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.59e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.59e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—kidney cancer	1.58e-06	2.69e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.58e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.57e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—kidney cancer	1.56e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—kidney cancer	1.55e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—kidney cancer	1.55e-06	2.63e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—kidney cancer	1.54e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—kidney cancer	1.53e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.52e-06	2.59e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—POMC—kidney cancer	1.52e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.46e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.42e-06	2.4e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—kidney cancer	1.21e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—kidney cancer	1.21e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.14e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTEN—kidney cancer	1.06e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.45e-07	1.27e-05	CbGpPWpGaD
